Pain News and Research

Latest Pain News and Research

Two Uofl professors provide reference works in oncology field

Two University of Louisville School of Medicine professors recently authored reference works in the field of oncology, one focusing on the use of radiation treatment for childhood cancers and the other on hepatocellular carcinoma, or liver cancer.

14 Feb 2011

Women need good nutrition and regular exercise

Obesity levels are at an all-time high among men, women, and children in the United States. The need for good nutrition and regular exercise is paramount for maintaining proper health and for keeping those extra pounds at bay, especially for women.

11 Feb 2011

AcelRx prices initial public offering at $5.00 per share

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced the pricing of its initial public offering of 8 million shares of common stock at $5.00 per share. All of the common stock will be sold by AcelRx.

11 Feb 2011

Looking at your body reduces pain

Simply looking at your body reduces pain, according to new research by scientists from UCL (University College London) and the University of Milano-Bicocca, Italy.

11 Feb 2011

RF-induced heat therapy could help treat common parasitic skin infection

Scientists are hoping that heat therapy could eventually replace a complex drug regimen as the first-line treatment of a parasitic skin infection common in tropical and subtropical regions of the world.

11 Feb 2011

AAOS appreciates FDA's communication on metal-on-metal hip components in total hip arthroplasty

The U.S. Food and Drug Administration (FDA) today posted a public health communication about metal-on-metal hip components used in total hip arthroplasty (THA). The American Academy of Orthopaedic Surgeons (AAOS) appreciates this thorough and well-considered look at the concerns surrounding the use of these implants.

11 Feb 2011

CHPA to lend its support for The Patients' Freedom to Choose Act

The Consumer Healthcare Products Association is pleased to lend its support for The Patients' Freedom to Choose Act, introduced today by Senator Kay Bailey Hutchison (R-Tex.) and Representative Erik Paulsen (R-Minn.) This important legislation would repeal a requirement enacted into law as part of the Patient Protection and Affordable Care Act of 2010 that requires consumers to obtain a prescription in order to utilize their flexible spending arrangements and health savings accounts to purchase over-the-counter medications.

11 Feb 2011

Zogenix completes enrollment in ZX002 Phase 3 study in opioid-experienced adults with moderate to severe pain

Zogenix, Inc. announced today the completion of enrollment in its pivotal Phase 3 efficacy study (Study 801) of ZX002. ZX002 is a novel, oral, single-entity, controlled-release formulation of hydrocodone for the treatment of moderate to severe pain in patients requiring around-the-clock opioid therapy for an extended period of time.

10 Feb 2011

Mallinckrodt receives FDA approval for Fentanyl Transdermal System patch ANDA

Covidien, a leading global provider of healthcare products, today announced that Mallinckrodt Inc., a Covidien company, has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New Drug Application (ANDA) for its Fentanyl Transdermal System (FTS) patch. Covidien is the largest supplier of controlled pain medications in the United States based on number of prescriptions.

10 Feb 2011

People with heart health issues, no insurance can benefit from Californians for Patient Care's online tool

People with heart health issues and little or no insurance can still get the preventive and maintenance care they need, by finding local no- and low-cost healthcare resources on Californians for Patient Care's MyHealthResource. The online tool, the only one of its kind in California, is free and confidential.

10 Feb 2011

Diamyd's NP2 Enkephalin Phase II study in cancer pain posted on ClinicalTrials.gov

Diamyd Medical´s US Phase II clinical trial, evaluating the ability of the candidate drug NP2 Enkephalin to reduce cancer pain, is posted on the ClinicalTrials.gov website.

10 Feb 2011

Florida pain clinic society opposes Gov. Scott's proposal to repeal Prescription Drug Monitoring Program

The Florida Society of Pain Management Providers opposes Governor Scott's proposal to repeal the Prescription Drug Monitoring Program (PDMP). The PDMP system is the single most important weapon in the war on Rx drug abuse, not only in Florida but in the other 42 states where legislators have approved their operation.

10 Feb 2011

New rotary-powered device for bone marrow aspiration, biopsy yields superior samples with less pain

For many cancer patients, a bone marrow biopsy and/or aspiration is one of the most dreaded aspects of their diagnosis and treatment plan. The traditional method for gaining bone marrow involves grinding a needle by hand through a patient's skin and bone, and the procedure is often described as extremely painful.

10 Feb 2011

Americans willing to pay more, but up to a limit, for safer food

Government regulators could more realistically assess the value of improving food safety if they considered the fact that consumers typically want to avoid getting sick - even if it means they have to pay a little extra for safer food, researchers say.

10 Feb 2011

State and federal efforts to monitor drug prescriptions and payments face challenges

The Center For Public Integrity reports on the challenges Medicare faces in trying to ensure that prescription drugs paid for by its contracting health plans are actually prescribed by doctors. Meanwhile, The Miami Herald chronicles the latest chapter in the ongoing story about the state's pill mills.

10 Feb 2011

Women use less of self-administered analgesic during labor

In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will present findings that show that when women administer their own patient-controlled epidural analgesia (PCEA) instead of getting a continuous epidural infusion (CEI) they used less analgesic, but reported similar levels of satisfaction.

10 Feb 2011

Rcadia receives FDA 510(k) clearance for enhanced COR Analyzer System to assess coronary branch vessels

Rcadia Medical Imaging announced today that it has received FDA 510(k) marketing clearance for an enhanced version of its COR Analyzer® System to assess coronary branch vessels in addition to main coronary arteries in patients with suspected coronary artery disease (CAD).

10 Feb 2011

Opinions: Polio vaccines; Alternatives to DDT, insecticides; Food price volatility; Global poverty; Foreign aid for vaccines

"No one denies" that the oral polio vaccine "has considerable merits. It's cheap to make. It's easy to administer; you don't need a trained nurse with a clean syringe [like the inactive vaccine needs], just a volunteer with a dropper. And it gives excellent immunity. ... But there are problems with the method," Wendy Orent, author of the book Plague: The Mysterious Past and Terrifying Future of the World's Most Dangerous Disease, writes in a Los Angeles Times opinion piece.

10 Feb 2011

PBNC technology may help detect cardiac disease, reduce diagnostic costs

Heart disease is a silent killer, but new microchip technology from Rice University is expected to advance the art of diagnosis.

9 Feb 2011

Protect Pharma completes sale of two patents and patents-applications to Grunenthal

Protect Pharmaceutical Corporation announced that it has completed the sale of two patents and patents-applications to Grunenthal GmbH, a German specialty pharmaceutical company that is a pioneer in pain drug discovery and research. The patent portfolio includes innovative pain drugs that address the large and underserved pain market.

9 Feb 2011

Pain News and Research

Latest Pain News and Research

Two Uofl professors provide reference works in oncology field

Women need good nutrition and regular exercise

AcelRx prices initial public offering at $5.00 per share

Looking at your body reduces pain

RF-induced heat therapy could help treat common parasitic skin infection

AAOS appreciates FDA's communication on metal-on-metal hip components in total hip arthroplasty

CHPA to lend its support for The Patients' Freedom to Choose Act

Zogenix completes enrollment in ZX002 Phase 3 study in opioid-experienced adults with moderate to severe pain

Mallinckrodt receives FDA approval for Fentanyl Transdermal System patch ANDA

People with heart health issues, no insurance can benefit from Californians for Patient Care's online tool

Diamyd's NP2 Enkephalin Phase II study in cancer pain posted on ClinicalTrials.gov

Florida pain clinic society opposes Gov. Scott's proposal to repeal Prescription Drug Monitoring Program

New rotary-powered device for bone marrow aspiration, biopsy yields superior samples with less pain

Americans willing to pay more, but up to a limit, for safer food

State and federal efforts to monitor drug prescriptions and payments face challenges

Women use less of self-administered analgesic during labor

Rcadia receives FDA 510(k) clearance for enhanced COR Analyzer System to assess coronary branch vessels

Opinions: Polio vaccines; Alternatives to DDT, insecticides; Food price volatility; Global poverty; Foreign aid for vaccines

PBNC technology may help detect cardiac disease, reduce diagnostic costs

Protect Pharma completes sale of two patents and patents-applications to Grunenthal

Industry Focus: Cell & Gene Therapy eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Pain News and Research

Latest Pain News and Research

Industry Focus: Cell & Gene Therapy eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in